Immediate Impact
2 from Science/Nature 55 standout
Citing Papers
Targeting mitophagy in neurodegenerative diseases
2025 Standout
GPCR drug discovery: new agents, targets and indications
2025 Standout
Works of Nancy Bélanger being referenced
Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
2010
Effect of a selective glutamate antagonist on l-dopa-induced dyskinesias in drug-naive parkinsonian monkeys
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nancy Bélanger | 348 | 403 | 27 | 98 | 13 | 569 | |
| Wai Kin D. Ko | 298 | 326 | 8 | 176 | 14 | 609 | |
| Ignacio Cruz‐Muros | 186 | 355 | 24 | 206 | 19 | 592 | |
| Kevin Chen | 157 | 266 | 12 | 220 | 13 | 560 | |
| Chandana Buddhala | 228 | 255 | 9 | 130 | 13 | 599 | |
| S. P. Markey | 263 | 282 | 23 | 98 | 10 | 495 | |
| Domingo Afonso‐Oramas | 150 | 312 | 22 | 195 | 20 | 542 | |
| Janaína K. Barbiero | 242 | 247 | 18 | 146 | 13 | 550 | |
| Filipa L. Campos | 256 | 310 | 33 | 118 | 11 | 609 | |
| Isabel Espadas | 168 | 341 | 10 | 205 | 16 | 588 | |
| Elvira Roda | 182 | 388 | 9 | 136 | 24 | 595 |
All Works
Loading papers...